Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2017, Article ID 8734504, 13 pages
https://doi.org/10.1155/2017/8734504
Review Article

Pulmonary Susceptibility of Neonates to Respiratory Syncytial Virus Infection: A Problem of Innate Immunity?

VIM, INRA, Université Paris-Saclay, Jouy-en-Josas, France

Correspondence should be addressed to Delphyne Descamps; rf.arni@spmacsed.enyhpled

Received 28 July 2017; Accepted 9 October 2017; Published 9 November 2017

Academic Editor: Elias Said

Copyright © 2017 Carole Drajac et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. E. Blount Jr., J. A. Morris, and R. E. Savage, “Recovery of cytopathogenic agent from chimpanzees with goryza,” Proceedings of the Society for Experimental Biology and Medicine, vol. 92, no. 3, pp. 544–549, 1956. View at Publisher · View at Google Scholar · View at Scopus
  2. R. Chanock and L. Finberg, “Recovery from infants with respiratory illness of a virus related to chimpanzee coryza agent (CCA). Epidemiologic aspects of infection in infants and young children,” American Journal of Epidemiology, vol. 66, no. 3, pp. 291–300, 1957. View at Publisher · View at Google Scholar
  3. R. Chanock, B. Roizman, and R. Myers, “Recovery from infants with respiratory illness of a virus related to chimpanzee coryza agent (CCA). Isolation, properties and characterization,” American Journal of Epidemiology, vol. 66, no. 3, pp. 281–290, 1957. View at Publisher · View at Google Scholar
  4. C. L. Afonso, G. K. Amarasinghe, K. Bányai et al., “Taxonomy of the order Mononegavirales: update 2016,” Archives of Virology, vol. 161, no. 8, pp. 2351–2360, 2016. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Connors, P. L. Collins, C. Y. Firestone, and B. R. Murphy, “Respiratory syncytial virus (RSV) F, G, M2 (22K), and N proteins each induce resistance to RSV challenge, but resistance induced by M2 and N proteins is relatively short-lived,” Journal of Virology, vol. 65, no. 3, pp. 1634–1637, 1991. View at Google Scholar
  6. S. Jain, W. H. Self, R. G. Wunderink, and CDC EPIC Study Team, “Community-acquired pneumonia requiring hospitalization,” New England Journal of Medicine, vol. 373, no. 24, p. 2382, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Jha, H. Jarvis, C. Fraser, and P. J. M. Openshaw, “Respiratory syncytial virus,” in SARS, MERS and Other Viral Lung Infections, D. S. Hui, G. A. Rossi, and S. L. Johnston, Eds., vol. 72, pp. 84–109, European Respiratory Society, Sheffield UK, 2016. View at Publisher · View at Google Scholar
  8. T. Shi, D. A. McAllister, K. L. O'Brien et al., “Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study,” The Lancet, vol. 390, no. 10098, pp. 946–958, 2017. View at Publisher · View at Google Scholar
  9. N. Sigurs, F. Aljassim, B. Kjellman et al., “Asthma and allergy patterns over 18 years after severe RSV bronchiolitis in the first year of life,” Thorax, vol. 65, no. 12, pp. 1045–1052, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. H. W. Kim, J. G. Canchola, C. D. Brandt et al., “Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine,” American Journal of Epidemiology, vol. 89, no. 4, pp. 422–434, 1969. View at Publisher · View at Google Scholar
  11. M. Connors, N. A. Giese, A. B. Kulkarni, C. Y. Firestone, H. C. Morse 3rd, and B. R. Murphy, “Enhanced pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of interleukin-4 (IL-4) and IL-10,” Journal of Virology, vol. 68, no. 8, pp. 5321–5325, 1994. View at Google Scholar
  12. M. E. Waris, C. Tsou, D. D. Erdman, S. R. Zaki, and L. J. Anderson, “Respiratory synctial virus infection in BALB/c mice previously immunized with formalin-inactivated virus induces enhanced pulmonary inflammatory response with a predominant Th2-like cytokine pattern,” Journal of Virology, vol. 70, no. 5, pp. 2852–2860, 1996. View at Google Scholar
  13. R. Janssen, L. Bont, C. L. Siezen et al., “Genetic susceptibility to respiratory syncytial virus bronchiolitis is predominantly associated with innate immune genes,” The Journal of Infectious Diseases, vol. 196, no. 6, pp. 826–834, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. L. Lambert, A. M. Sagfors, P. J. Openshaw, and F. J. Culley, “Immunity to RSV in early-life,” Frontiers in Immunology, vol. 5, p. 466, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. S. A. Cormier, D. You, and S. Honnegowda, “The use of a neonatal mouse model to study respiratory syncytial virus infections,” Expert Review of Anti-Infective Therapy, vol. 8, no. 12, pp. 1371–1380, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. R. Ochola, C. Sande, G. Fegan et al., “The level and duration of RSV-specific maternal IgG in infants in Kilifi Kenya,” PLoS One, vol. 4, no. 12, article e8088, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. C. J. Sande, P. A. Cane, and D. J. Nokes, “The association between age and the development of respiratory syncytial virus neutralising antibody responses following natural infection in infants,” Vaccine, vol. 32, no. 37, pp. 4726–4729, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. M. O. Blanken, M. M. Rovers, J. M. Molenaar et al., “Respiratory syncytial virus and recurrent wheeze in healthy preterm infants,” New England Journal of Medicine, vol. 368, no. 19, pp. 1791–1799, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. F. J. Culley, J. Pollott, and P. J. Openshaw, “Age at first viral infection determines the pattern of T cell-mediated disease during reinfection in adulthood,” The Journal of Experimental Medicine, vol. 196, no. 10, pp. 1381–1386, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Dakhama, J. W. Park, C. Taube et al., “The enhancement or prevention of airway hyperresponsiveness during reinfection with respiratory syncytial virus is critically dependent on the age at first infection and IL-13 production,” Journal of Immunology, vol. 175, no. 3, pp. 1876–1883, 2005. View at Publisher · View at Google Scholar
  21. J. C. Schittny, “Development of the lung,” Cell and Tissue Research, vol. 367, no. 3, pp. 427–444, 2017. View at Publisher · View at Google Scholar
  22. S. I. Mund, M. Stampanoni, and J. C. Schittny, “Developmental alveolarization of the mouse lung,” Developmental Dynamics, vol. 237, no. 8, pp. 2108–2116, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. E. S. Gollwitzer and B. J. Marsland, “Impact of early-life exposures on immune maturation and susceptibility to disease,” Trends in Immunology, vol. 36, no. 11, pp. 684–696, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. C. M. Lloyd and B. J. Marsland, “Lung homeostasis: influence of age, microbes, and the immune system,” Immunity, vol. 46, no. 4, pp. 549–561, 2017. View at Publisher · View at Google Scholar
  25. M. Guilliams, I. De Kleer, S. Henri et al., “Alveolar macrophages develop from fetal monocytes that differentiate into long-lived cells in the first week of life via GM-CSF,” The Journal of Experimental Medicine, vol. 210, no. 10, pp. 1977–1992, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. C. Schneider, S. P. Nobs, M. Kurrer, H. Rehrauer, C. Thiele, and M. Kopf, “Induction of the nuclear receptor PPAR-γ by the cytokine GM-CSF is critical for the differentiation of fetal monocytes into alveolar macrophages,” Nature Immunology, vol. 15, no. 11, pp. 1026–1037, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. I. M. de Kleer, M. Kool, M. J. de Bruijn et al., “Perinatal activation of the interleukin-33 pathway promotes type 2 immunity in the developing lung,” Immunity, vol. 45, no. 6, pp. 1285–1298, 2016. View at Publisher · View at Google Scholar · View at Scopus
  28. B. L. Manroe, A. G. Weinberg, C. R. Rosenfeld, and R. Browne, “The neonatal blood count in health and disease. I. Reference values for neutrophilic cells,” The Journal of Pediatrics, vol. 95, no. 1, pp. 89–98, 1979. View at Publisher · View at Google Scholar · View at Scopus
  29. H. S. Deshmukh, Y. Liu, O. R. Menkiti et al., “The microbiota regulates neutrophil homeostasis and host resistance to Escherichia coli K1 sepsis in neonatal mice,” Nature Medicine, vol. 20, no. 5, pp. 524–530, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Saluzzo, A. D. Gorki, B. M. J. Rana et al., “First-breath-induced type 2 pathways shape the lung immune environment,” Cell Reports, vol. 18, no. 8, pp. 1893–1905, 2017. View at Publisher · View at Google Scholar
  31. A. M. Miller, “Role of IL-33 in inflammation and disease,” Journal of Inflammation, vol. 8, no. 1, p. 22, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. J. Lu, J. Kang, C. Zhang, and X. Zhang, “The role of IL-33/ST2L signals in the immune cells,” Immunology Letters, vol. 164, no. 1, pp. 11–17, 2015. View at Publisher · View at Google Scholar · View at Scopus
  33. H. Spits, D. Artis, M. Colonna et al., “Innate lymphoid cells — a proposal for uniform nomenclature,” Nature Reviews Immunology, vol. 13, no. 2, pp. 145–149, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. G. Gasteiger, X. Fan, S. Dikiy, S. Y. Lee, and A. Y. Rudensky, “Tissue residency of innate lymphoid cells in lymphoid and nonlymphoid organs,” Science, vol. 350, no. 6263, pp. 981–985, 2015. View at Publisher · View at Google Scholar · View at Scopus
  35. C. H. Kim, S. Hashimoto-Hill, and M. Kim, “Migration and tissue tropism of innate lymphoid cells,” Trends in Immunology, vol. 37, no. 1, pp. 68–79, 2016. View at Publisher · View at Google Scholar · View at Scopus
  36. C. Gregoire, L. Chasson, C. Luci et al., “The trafficking of natural killer cells,” Immunological Reviews, vol. 220, pp. 169–182, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Greter, J. Helft, A. Chow et al., “GM-CSF controls nonlymphoid tissue dendritic cell homeostasis but is dispensable for the differentiation of inflammatory dendritic cells,” Immunity, vol. 36, no. 6, pp. 1031–1046, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. X. Roux, A. Remot, A. Petit-Camurdan et al., “Neonatal lung immune responses show a shift of cytokines and transcription factors toward Th2 and a deficit in conventional and plasmacytoid dendritic cells,” European Journal of Immunology, vol. 41, no. 10, pp. 2852–2861, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. J. Han, A. Dakhama, Y. Jia et al., “Responsiveness to respiratory syncytial virus in neonates is mediated through thymic stromal lymphopoietin and OX40 ligand,” The Journal of Allergy and Clinical Immunology, vol. 130, no. 5, pp. 1175–1186.e9, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. C. M. Sun, E. Deriaud, C. Leclerc, and R. Lo-Man, “Upon TLR9 signaling, CD5+ B cells control the IL-12-dependent Th1-priming capacity of neonatal DCs,” Immunity, vol. 22, no. 4, pp. 467–477, 2005. View at Publisher · View at Google Scholar · View at Scopus
  41. D. Zhivaki, S. Lemoine, A. Lim et al., “Respiratory syncytial virus infects regulatory B cells in human neonates via chemokine receptor CX3CR1 and promotes lung disease severity,” Immunity, vol. 46, no. 2, pp. 301–314, 2017. View at Publisher · View at Google Scholar
  42. E. S. Gollwitzer, S. Saglani, A. Trompette et al., “Lung microbiota promotes tolerance to allergens in neonates via PD-L1,” Nature Medicine, vol. 20, no. 6, pp. 642–647, 2014. View at Publisher · View at Google Scholar · View at Scopus
  43. A. Remot, D. Descamps, M. L. Noordine et al., “Bacteria isolated from lung modulate asthma susceptibility in mice,” The ISME Journal, vol. 11, no. 5, pp. 1061–1074, 2017. View at Publisher · View at Google Scholar
  44. Y. Yun, G. Srinivas, S. Kuenzel et al., “Environmentally determined differences in the murine lung microbiota and their relation to alveolar architecture,” PLoS One, vol. 9, no. 12, article e113466, 2014. View at Publisher · View at Google Scholar · View at Scopus
  45. T. Olszak, D. An, S. Zeissig et al., “Microbial exposure during early life has persistent effects on natural killer T cell function,” Science, vol. 336, no. 6080, pp. 489–493, 2012. View at Publisher · View at Google Scholar · View at Scopus
  46. T. Gensollen, S. S. Iyer, D. L. Kasper, and R. S. Blumberg, “How colonization by microbiota in early life shapes the immune system,” Science, vol. 352, no. 6285, pp. 539–544, 2016. View at Publisher · View at Google Scholar · View at Scopus
  47. C. Johansson, “Respiratory syncytial virus infection: an innate perspective,” F1000Research, vol. 5, p. 2898, 2016. View at Publisher · View at Google Scholar
  48. T. H. Kim and H. K. Lee, “Innate immune recognition of respiratory syncytial virus infection,” BMB Reports, vol. 47, no. 4, pp. 184–191, 2014. View at Publisher · View at Google Scholar · View at Scopus
  49. N. Marr, S. E. Turvey, and N. Grandvaux, “Pathogen recognition receptor crosstalk in respiratory syncytial virus sensing: a host and cell type perspective,” Trends in Microbiology, vol. 21, no. 11, pp. 568–574, 2013. View at Publisher · View at Google Scholar · View at Scopus
  50. R. Zeng, Y. Cui, Y. Hai, and Y. Liu, “Pattern recognition receptors for respiratory syncytial virus infection and design of vaccines,” Virus Research, vol. 167, no. 2, pp. 138–145, 2012. View at Publisher · View at Google Scholar · View at Scopus
  51. E. A. Kurt-Jones, L. Popova, L. Kwinn et al., “Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus,” Nature Immunology, vol. 1, no. 5, pp. 398–401, 2000. View at Publisher · View at Google Scholar
  52. L. M. Haynes, D. D. Moore, E. A. Kurt-Jones, R. W. Finberg, L. J. Anderson, and R. A. Tripp, “Involvement of toll-like receptor 4 in innate immunity to respiratory syncytial virus,” Journal of Virology, vol. 75, no. 22, pp. 10730–10737, 2001. View at Publisher · View at Google Scholar · View at Scopus
  53. S. Ehl, R. Bischoff, T. Ostler et al., “The role of Toll-like receptor 4 versus interleukin-12 in immunity to respiratory syncytial virus,” European Journal of Immunology, vol. 34, no. 4, pp. 1146–1153, 2004. View at Publisher · View at Google Scholar · View at Scopus
  54. L. Armstrong, A. R. Medford, K. M. Uppington et al., “Expression of functional toll-like receptor-2 and -4 on alveolar epithelial cells,” American Journal of Respiratory Cell and Molecular Biology, vol. 31, no. 2, pp. 241–245, 2004. View at Publisher · View at Google Scholar · View at Scopus
  55. K. Suzuki, T. Suda, T. Naito, K. Ide, K. Chida, and H. Nakamura, “Impaired toll-like receptor 9 expression in alveolar macrophages with no sensitivity to CpG DNA,” American Journal of Respiratory and Critical Care Medicine, vol. 171, no. 7, pp. 707–713, 2005. View at Publisher · View at Google Scholar · View at Scopus
  56. M. Vareille, E. Kieninger, M. R. Edwards, and N. Regamey, “The airway epithelium: soldier in the fight against respiratory viruses,” Clinical Microbiology Reviews, vol. 24, no. 1, pp. 210–229, 2011. View at Publisher · View at Google Scholar · View at Scopus
  57. K. A. Shirey, L. M. Pletneva, A. C. Puche et al., “Control of RSV-induced lung injury by alternatively activated macrophages is IL-4Rα-, TLR4-, and IFN-β-dependent,” Mucosal Immunology, vol. 3, no. 3, pp. 291–300, 2010. View at Publisher · View at Google Scholar · View at Scopus
  58. M. R. Murawski, G. N. Bowen, A. M. Cerny et al., “Respiratory syncytial virus activates innate immunity through Toll-like receptor 2,” Journal of Virology, vol. 83, no. 3, pp. 1492–1500, 2009. View at Publisher · View at Google Scholar · View at Scopus
  59. G. F. Sonnenberg and D. Artis, “Innate lymphoid cells in the initiation, regulation and resolution of inflammation,” Nature Medicine, vol. 21, no. 7, pp. 698–708, 2015. View at Publisher · View at Google Scholar · View at Scopus
  60. T. Ishii, K. Hosoki, Y. Niikura, T. Nagase, and N. Yamashita, “The activation of pulmonary type2 innate lymphoid cells through toll-like receptors,” American Journal of Respiratory and Critical Care Medicine, vol. 195, article AS284, 2017. View at Google Scholar
  61. B. D. Rudd, E. Burstein, C. S. Duckett, X. Li, and N. W. Lukacs, “Differential role for TLR3 in respiratory syncytial virus-induced chemokine expression,” Journal of Virology, vol. 79, no. 6, pp. 3350–3357, 2005. View at Publisher · View at Google Scholar · View at Scopus
  62. L. Guillot, R. Le Goffic, S. Bloch et al., “Involvement of toll-like receptor 3 in the immune response of lung epithelial cells to double-stranded RNA and influenza A virus,” The Journal of Biological Chemistry, vol. 280, no. 7, pp. 5571–5580, 2005. View at Publisher · View at Google Scholar · View at Scopus
  63. F. Qi, D. Wang, J. Liu et al., “Respiratory macrophages and dendritic cells mediate respiratory syncytial virus-induced IL-33 production in TLR3- or TLR7-dependent manner,” International Immunopharmacology, vol. 29, no. 2, pp. 408–415, 2015. View at Publisher · View at Google Scholar · View at Scopus
  64. T. Demoor, B. C. Petersen, S. Morris et al., “IPS-1 signaling has a nonredundant role in mediating antiviral responses and the clearance of respiratory syncytial virus,” Journal of Immunology, vol. 189, no. 12, pp. 5942–5953, 2012. View at Publisher · View at Google Scholar · View at Scopus
  65. N. W. Lukacs, J. J. Smit, S. Mukherjee, S. B. Morris, G. Nunez, and D. M. Lindell, “Respiratory virus-induced TLR7 activation controls IL-17-associated increased mucus via IL-23 regulation,” Journal of Immunology, vol. 185, no. 4, pp. 2231–2239, 2010. View at Publisher · View at Google Scholar · View at Scopus
  66. S. Phipps, C. E. Lam, S. Mahalingam et al., “Eosinophils contribute to innate antiviral immunity and promote clearance of respiratory syncytial virus,” Blood, vol. 110, no. 5, pp. 1578–1586, 2007. View at Publisher · View at Google Scholar · View at Scopus
  67. J. Schlender, V. Hornung, S. Finke et al., “Inhibition of toll-like receptor 7- and 9-mediated alpha/beta interferon production in human plasmacytoid dendritic cells by respiratory syncytial virus and measles virus,” Journal of Virology, vol. 79, no. 9, pp. 5507–5515, 2005. View at Publisher · View at Google Scholar · View at Scopus
  68. Y. M. Loo, J. Fornek, N. Crochet et al., “Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity,” Journal of Virology, vol. 82, no. 1, pp. 335–345, 2008. View at Publisher · View at Google Scholar · View at Scopus
  69. N. Marr, T. I. Wang, S. H. Kam et al., “Attenuation of respiratory syncytial virus-induced and RIG-I-dependent type I IFN responses in human neonates and very young children,” Journal of Immunology, vol. 192, no. 3, pp. 948–957, 2014. View at Publisher · View at Google Scholar · View at Scopus
  70. M. Goritzka, S. Makris, F. Kausar et al., “Alveolar macrophage-derived type I interferons orchestrate innate immunity to RSV through recruitment of antiviral monocytes,” The Journal of Experimental Medicine, vol. 212, no. 5, pp. 699–714, 2015. View at Publisher · View at Google Scholar · View at Scopus
  71. A. Sabbah, T. H. Chang, R. Harnack et al., “Activation of innate immune antiviral responses by Nod2,” Nature Immunology, vol. 10, no. 10, pp. 1073–1080, 2009. View at Publisher · View at Google Scholar · View at Scopus
  72. V. G. Bhoj, Q. Sun, E. J. Bhoj et al., “MAVS and MyD88 are essential for innate immunity but not cytotoxic T lymphocyte response against respiratory syncytial virus,” Proceedings of the National Academy of Sciences, vol. 105, no. 37, pp. 14046–14051, 2008. View at Publisher · View at Google Scholar · View at Scopus
  73. S. Makris, M. Bajorek, F. J. Culley, M. Goritzka, and C. Johansson, “Alveolar macrophages can control respiratory syncytial virus infection in the absence of type I interferons,” Journal of Innate Immunity, vol. 8, no. 5, pp. 452–463, 2016. View at Publisher · View at Google Scholar · View at Scopus
  74. A. A. Awomoyi, P. Rallabhandi, T. I. Pollin et al., “Association of TLR4 polymorphisms with symptomatic respiratory syncytial virus infection in high-risk infants and young children,” Journal of Immunology, vol. 179, no. 5, pp. 3171–3177, 2007. View at Publisher · View at Google Scholar
  75. G. Tal, A. Mandelberg, I. Dalal et al., “Association between common Toll-like receptor 4 mutations and severe respiratory syncytial virus disease,” The Journal of Infectious Diseases, vol. 189, no. 11, pp. 2057–2063, 2004. View at Publisher · View at Google Scholar · View at Scopus
  76. M. K. Tulic, R. J. Hurrelbrink, C. M. Prêle et al., “TLR4 polymorphisms mediate impaired responses to respiratory syncytial virus and lipopolysaccharide,” Journal of Immunology, vol. 179, no. 1, pp. 132–140, 2007. View at Publisher · View at Google Scholar
  77. M. Ramet, M. Korppi, and M. Hallman, “Pattern recognition receptors and genetic risk for rsv infection: value for clinical decision-making?” Pediatric Pulmonology, vol. 46, no. 2, pp. 101–110, 2011. View at Publisher · View at Google Scholar · View at Scopus
  78. N. Marr, A. F. Hirschfeld, A. Lam, S. Wang, P. M. Lavoie, and S. E. Turvey, “Assessment of genetic associations between common single nucleotide polymorphisms in RIG-I-like receptor and IL-4 signaling genes and severe respiratory syncytial virus infection in children: a candidate gene case-control study,” PLoS One, vol. 9, no. 6, article e100269, 2014. View at Publisher · View at Google Scholar · View at Scopus
  79. M. T. Caballero, M. E. Serra, P. L. Acosta et al., “TLR4 genotype and environmental LPS mediate RSV bronchiolitis through Th2 polarization,” The Journal of Clinical Investigation, vol. 125, no. 2, pp. 571–582, 2015. View at Publisher · View at Google Scholar · View at Scopus
  80. T. R. Kollmann, O. Levy, R. R. Montgomery, and S. Goriely, “Innate immune function by Toll-like receptors: distinct responses in newborns and the elderly,” Immunity, vol. 37, no. 5, pp. 771–783, 2012. View at Publisher · View at Google Scholar · View at Scopus
  81. K. Gabehart, K. A. Correll, J. E. Loader, C. W. White, and A. Dakhama, “The lung response to ozone is determined by age and is partially dependent on toll-like receptor 4,” Respiratory Research, vol. 16, p. 117, 2015. View at Publisher · View at Google Scholar · View at Scopus
  82. K. Harju, M. Ojaniemi, S. Rounioja et al., “Expression of toll-like receptor 4 and endotoxin responsiveness in mice during perinatal period,” Pediatric Research, vol. 57, no. 5, Part 1, pp. 644–648, 2005. View at Publisher · View at Google Scholar · View at Scopus
  83. J. S. Tregoning, Y. Yamaguchi, J. Harker, B. Wang, and P. J. Openshaw, “The role of T cells in the enhancement of respiratory syncytial virus infection severity during adult reinfection of neonatally sensitized mice,” Journal of Virology, vol. 82, no. 8, pp. 4115–4124, 2008. View at Publisher · View at Google Scholar · View at Scopus
  84. A. F. Christiaansen, C. J. Knudson, K. A. Weiss, and S. M. Varga, “The CD4 T cell response to respiratory syncytial virus infection,” Immunologic Research, vol. 59, no. 1–3, pp. 109–117, 2014. View at Publisher · View at Google Scholar · View at Scopus
  85. T. J. Ruckwardt, A. M. Malloy, K. M. Morabito, and B. S. Graham, “Quantitative and qualitative deficits in neonatal lung-migratory dendritic cells impact the generation of the CD8+ T cell response,” PLoS Pathogens, vol. 10, no. 2, article e1003934, 2014. View at Publisher · View at Google Scholar · View at Scopus
  86. S. A. Cormier, B. Shrestha, J. Saravia et al., “Limited type I interferons and plasmacytoid dendritic cells during neonatal respiratory syncytial virus infection permit immunopathogenesis upon reinfection,” Journal of Virology, vol. 88, no. 16, pp. 9350–9360, 2014. View at Publisher · View at Google Scholar · View at Scopus
  87. A. Remot, D. Descamps, L. Jouneau et al., “Flt3 ligand improves the innate response to respiratory syncytial virus and limits lung disease upon RSV reexposure in neonate mice,” European Journal of Immunology, vol. 46, no. 4, pp. 874–884, 2016. View at Publisher · View at Google Scholar · View at Scopus
  88. M. Goritzka, L. R. Durant, C. Pereira, S. Salek-Ardakani, P. J. Openshaw, and C. Johansson, “Alpha/beta interferon receptor signaling amplifies early proinflammatory cytokine production in the lung during respiratory syncytial virus infection,” Journal of Virology, vol. 88, no. 11, pp. 6128–6136, 2014. View at Publisher · View at Google Scholar · View at Scopus
  89. T. R. Johnson, S. E. Mertz, N. Gitiban et al., “Role for innate IFNs in determining respiratory syncytial virus immunopathology,” Journal of Immunology, vol. 174, no. 11, pp. 7234–7241, 2005. View at Publisher · View at Google Scholar
  90. K. M. Eichinger, L. Egaña, J. G. Orend et al., “Alveolar macrophages support interferon gamma-mediated viral clearance in RSV-infected neonatal mice,” Respiratory Research, vol. 16, p. 122, 2015. View at Publisher · View at Google Scholar · View at Scopus
  91. P. K. Pribul, J. Harker, B. Wang et al., “Alveolar macrophages are a major determinant of early responses to viral lung infection but do not influence subsequent disease development,” Journal of Virology, vol. 82, no. 9, pp. 4441–4448, 2008. View at Publisher · View at Google Scholar · View at Scopus
  92. D. Kolli, M. R. Gupta, E. Sbrana et al., “Alveolar macrophages contribute to the pathogenesis of human metapneumovirus infection while protecting against respiratory syncytial virus infection,” American Journal of Respiratory Cell and Molecular Biology, vol. 51, no. 4, pp. 502–515, 2014. View at Publisher · View at Google Scholar · View at Scopus
  93. T. Hussell and T. J. Bell, “Alveolar macrophages: plasticity in a tissue-specific context,” Nature Reviews Immunology, vol. 14, no. 2, pp. 81–93, 2014. View at Publisher · View at Google Scholar · View at Scopus
  94. D. M. Mosser and J. P. Edwards, “Exploring the full spectrum of macrophage activation,” Nature Reviews Immunology, vol. 8, no. 12, pp. 958–969, 2008. View at Publisher · View at Google Scholar · View at Scopus
  95. K. M. Empey, J. G. Orend, R. S. Peebles Jr. et al., “Stimulation of immature lung macrophages with intranasal interferon gamma in a novel neonatal mouse model of respiratory syncytial virus infection,” PLoS One, vol. 7, no. 7, article e40499, 2012. View at Publisher · View at Google Scholar · View at Scopus
  96. J. Saravia, D. You, B. Shrestha et al., “Respiratory syncytial virus disease is mediated by age-variable IL-33,” PLoS Pathogens, vol. 11, no. 10, article e1005217, 2015. View at Publisher · View at Google Scholar · View at Scopus
  97. M. L. Garcia-Garcia, C. Calvo, A. Moreira et al., “Thymic stromal lymphopoietin, IL-33, and periostin in hospitalized infants with viral bronchiolitis,” Medicine, vol. 96, no. 18, article e6787, 2017. View at Publisher · View at Google Scholar
  98. M. T. Stier, M. H. Bloodworth, S. Toki et al., “Respiratory syncytial virus infection activates IL-13-producing group 2 innate lymphoid cells through thymic stromal lymphopoietin,” The Journal of Allergy and Clinical Immunology, vol. 138, no. 3, pp. 814–824.e11, 2016. View at Publisher · View at Google Scholar · View at Scopus
  99. S. Sattler, G. S. Ling, D. Xu et al., “IL-10-producing regulatory B cells induced by IL-33 (BregIL-33) effectively attenuate mucosal inflammatory responses in the gut,” Journal of Autoimmunity, vol. 50, pp. 107–122, 2014. View at Publisher · View at Google Scholar · View at Scopus
  100. Y. Yamaguchi, J. A. Harker, B. Wang, P. J. Openshaw, J. S. Tregoning, and F. J. Culley, “Preexposure to CpG protects against the delayed effects of neonatal respiratory syncytial virus infection,” Journal of Virology, vol. 86, no. 19, pp. 10456–10461, 2012. View at Publisher · View at Google Scholar · View at Scopus
  101. M. S. Boukhvalova, T. B. Sotomayor, R. C. Point, L. M. Pletneva, G. A. Prince, and J. C. Blanco, “Activation of interferon response through toll-like receptor 3 impacts viral pathogenesis and pulmonary toll-like receptor expression during respiratory syncytial virus and influenza infections in the cotton rat Sigmodon hispidus model,” Journal of Interferon & Cytokine Research, vol. 30, no. 4, pp. 229–242, 2010. View at Publisher · View at Google Scholar · View at Scopus
  102. S. Challa, A. Sheri, S. Padmanabhan et al., “Prophylactic and therapeutic anti-RSV activity of SB 9200 – a novel agent that activates RIG-I and NOD2,” in Spring Bank Pharmaceuticals Presents Data on Immunomodulatory Agent SB 9200 at the 29th International Conference on Antiviral Research, La Jolla, CA, 2016.
  103. K. K. Tekkanat, H. F. Maassab, D. S. Cho et al., “IL-13-induced airway hyperreactivity during respiratory syncytial virus infection is STAT6 dependent,” Journal of Immunology, vol. 166, no. 5, pp. 3542–3548, 2001. View at Publisher · View at Google Scholar
  104. G. M. Gauvreau, P. M. O'Byrne, L. P. Boulet et al., “Effects of an anti-TSLP antibody on allergen-induced asthmatic responses,” New England Journal of Medicine, vol. 370, no. 22, pp. 2102–2110, 2014. View at Publisher · View at Google Scholar · View at Scopus
  105. E. H. De Boever, C. Ashman, A. P. Cahn et al., “Efficacy and safety of an anti-IL-13 mAb in patients with severe asthma: a randomized trial,” Journal of Allergy and Clinical Immunology, vol. 133, no. 4, pp. 989–996, 2014. View at Publisher · View at Google Scholar · View at Scopus
  106. B. Shrestha, D. You, J. Saravia et al., “IL-4Rα on dendritic cells in neonates and Th2 immunopathology in respiratory syncytial virus infection,” Journal of Leukocyte Biology, vol. 102, no. 1, pp. 153–161, 2017. View at Publisher · View at Google Scholar
  107. M. J. Ripple, D. You, S. Honnegowda et al., “Immunomodulation with IL-4Rα antisense oligonucleotide prevents respiratory syncytial virus-mediated pulmonary disease,” Journal of Immunology, vol. 185, no. 8, pp. 4804–4811, 2010. View at Publisher · View at Google Scholar · View at Scopus
  108. B. T. Srinivasa, K. H. Restori, J. Shan et al., “STAT6 inhibitory peptide given during RSV infection of neonatal mice reduces exacerbated airway responses upon adult reinfection,” Journal of Leukocyte Biology, vol. 101, no. 2, pp. 519–529, 2017. View at Publisher · View at Google Scholar
  109. Y. M. Lee, N. Miyahara, K. Takeda et al., “IFN-γ production during initial infection determines the outcome of reinfection with respiratory syncytial virus,” American Journal of Respiratory and Critical Care Medicine, vol. 177, no. 2, pp. 208–218, 2008. View at Publisher · View at Google Scholar · View at Scopus
  110. K. M. Eichinger, E. Resetar, J. Orend, K. Anderson, and K. M. Empey, “Age predicts cytokine kinetics and innate immune cell activation following intranasal delivery of IFNγ and GM-CSF in a mouse model of RSV infection,” Cytokine, vol. 97, pp. 25–37, 2017. View at Publisher · View at Google Scholar
  111. J. P. Lynch, M. A. Sikder, B. F. Curren et al., “The influence of the microbiome on early-life severe viral lower respiratory infections and asthma-food for thought?” Frontiers in Immunology, vol. 8, p. 156, 2017. View at Publisher · View at Google Scholar
  112. J. Villena, S. Salva, M. Núñez et al., “Probiotics for everyone! The novel immunobiotic Lactobacillus rhamnosus CRL1505 and the beginning of social probiotic programs in Argentina,” International Journal of Biotechnology for Wellness Industries, vol. 1, no. 3, pp. 189–198, 2012. View at Publisher · View at Google Scholar
  113. J. Villena, E. Chiba, Y. Tomosada et al., “Orally administered Lactobacillus rhamnosus modulates the respiratory immune response triggered by the viral pathogen-associated molecular pattern poly(I:C),” BMC Immunology, vol. 13, p. 53, 2012. View at Publisher · View at Google Scholar · View at Scopus
  114. E. Chiba, Y. Tomosada, M. G. Vizoso-Pinto et al., “Immunobiotic Lactobacillus rhamnosus improves resistance of infant mice against respiratory syncytial virus infection,” International Immunopharmacology, vol. 17, no. 2, pp. 373–382, 2013. View at Publisher · View at Google Scholar · View at Scopus
  115. Y. Tomosada, E. Chiba, H. Zelaya et al., “Nasally administered Lactobacillus rhamnosus strains differentially modulate respiratory antiviral immune responses and induce protection against respiratory syncytial virus infection,” BMC Immunology, vol. 14, p. 40, 2013. View at Publisher · View at Google Scholar · View at Scopus
  116. W. A. de Steenhuijsen Piters, S. Heinonen, R. Hasrat et al., “Nasopharyngeal microbiota, host transcriptome, and disease severity in children with respiratory syncytial virus infection,” American Journal of Respiratory and Critical Care Medicine, vol. 194, no. 9, pp. 1104–1115, 2016. View at Publisher · View at Google Scholar · View at Scopus
  117. S. M. Teo, D. Mok, K. Pham et al., “The infant nasopharyngeal microbiome impacts severity of lower respiratory infection and risk of asthma development,” Cell Host & Microbe, vol. 17, no. 5, pp. 704–715, 2015. View at Publisher · View at Google Scholar · View at Scopus